Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Cosen Biology is a specialized biotechnology firm based in China that focuses on the research, production, and distribution of high-quality collagen and gelatin products. The company utilizes advanced enzymatic hydrolysis technology to manufacture bovine and fish-derived collagen peptides for the global health, beauty, and pharmaceutical markets. Their product portfolio is widely applied in dietary supplements, functional foods, and cosmetic formulations aimed at improving skin elasticity, joint function, and bone density. Cosen Biology operates a large-scale manufacturing facility in Jiangxi province that adheres to international quality standards, including GMP, ISO, and HALAL certifications. By providing high-purity raw materials, the company supports various international brands in developing health-focused consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Cosen Biology.